February 21, 2006Annals of Internal Medicine

Reporting of Drug Tolerance in Randomized Clinical Trials: When Data Conflict with Authors' Conclusions

View Full Paper

Ask AI

Bookmark

Design

Editorial

Authors

AJA.‐P. Jonville‐BéraUniversité de Tours BGBruno GiraudeauUniversité de Tours EAE. Autret‐LecaUniversité de Tours

Discussion

Member takes

Implication

This letter emphasizes the importance of objective safety reporting in clinical trials, warning against interpreting a lack of statistical significance as proof of safety.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jonville‐Béra et al. (2006) studied this question.

synapsesocial.com/papers/6a70b96bc92390ac2d07d3a3 https://doi.org/10.7326/0003-4819-144-4-200602210-00024

View Full Paper

Ask AI

Bookmark

Implication

This letter emphasizes the importance of objective safety reporting in clinical trials, warning against interpreting a lack of statistical significance as proof of safety.

Reporting of Drug Tolerance in Randomized Clinical Trials: When Data Conflict with Authors' Conclusions

Discussion

Member takes

Implication

Key Points

Cite This Study

Reporting of Drug Tolerance in Randomized Clinical Trials: When Data Conflict with Authors' Conclusions

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider